Cargando…

Prolonged Postoperative Vasoplegia in Pediatric Patients on Chronic Angiotensin II Blocker Treatment

Prolonged postoperative vasoplegia is known to occur following cardiac surgery in patients on chronic angiotensin II receptor blocker (ARB) treatment in adults. The perioperative management of these drugs in the pediatric population is not well described and here we would like to highlight this fact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandya, Nischal R., Alphonso, Nelson, Tu, Quyen, Venugopal, Prem, Schlapbach, Luregn J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131193/ https://www.ncbi.nlm.nih.gov/pubmed/30234130 http://dx.doi.org/10.3389/fcvm.2018.00121

Ejemplares similares

The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia
por: Papazisi, Olga, et al.
Publicado: (2020)

Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting
por: Sovic, William, et al.
Publicado: (2021)

Commentary: Angiotensin II for vasoplegia: A desperate measure for desperate times
por: Balsam, Leora B.
Publicado: (2020)

Successful use of angiotensin II for vasoplegia after thoracoabdominal aortic aneurysm repair
por: Chatterjee, Subhasis, et al.
Publicado: (2020)

Protocol Compliance Guiding Angiotensin II Use in Post Cardiovascular Surgery Vasoplegia
por: ten Lohuis, Caitlin C., et al.
Publicado: (2022)

Rapid reversal of vasoplegia with methylene blue in calcium channel blocker poisoning
por: Saha, Biplab K., et al.
Publicado: (2020)

Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy
por: Tu, Bin, et al.
Publicado: (2021)

Vasoplegia: A Review
por: Ratnani, Iqbal, et al.
Publicado: (2023)

The Durability of Intravenous Hydroxocobalamin in Vasoplegia
por: Blaha, Madeline, et al.
Publicado: (2023)

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?
por: Simko, Fedor, et al.
Publicado: (2021)

Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on the Inflammatory Response and Viral Clearance in COVID-19 Patients
por: Huang, Linna, et al.
Publicado: (2021)

Vasoplegia treatments: the past, the present, and the future
por: Levy, Bruno, et al.
Publicado: (2018)

SAT-562 Angiotensin II Induces Aldosterone Synthesis in the Rat Heart Stressed by Angiotensin II
por: Bose, Himangshu S, et al.
Publicado: (2020)

Diagnostic Accuracy of Infection Markers to Diagnose Infections in Neonates and Children Receiving Extracorporeal Membrane Oxygenation
por: Doo, Irene, et al.
Publicado: (2022)

Neuroendocrine predictors of vasoplegia after cardiopulmonary bypass
por: Pasero, D., et al.
Publicado: (2020)

Vasoplegia: Mechanism and Management Following Cardiopulmonary Bypass
por: Muhammad, Rizal, et al.
Publicado: (2022)

Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly (PARAMETER) study
por: Williams, Bryan, et al.
Publicado: (2014)

Effect of preoperative renin-angiotensin system blockade on vasoplegia after cardiac surgery: A systematic review with meta-analysis
por: Noubiap, Jean Jacques, et al.
Publicado: (2022)

REstrictive versus StandarD FlUid Management in Mechanically Ventilated ChildrEn Admitted to PICU: study protocol for a pilot randomised controlled trial (REDUCE-1)
por: Raman, Sainath, et al.
Publicado: (2023)

Angiotensin Converting-Enzyme Inhibitors, Angiotensin Receptor Blockers, and Calcium Channel Blockers Are Associated with Prolonged Vascular Access Patency in Uremic Patients Undergoing Hemodialysis
por: Chen, Fu-An, et al.
Publicado: (2016)

Angiotensin II Receptor Blockers and Arrhythmias in Ventricular Hypertrophy
por: Salama, Guy
Publicado: (2022)

Clinical Pharmacogenetics of Angiotensin II Receptor Blockers in Iraq
por: Al-Hussaniy, Hany A., et al.
Publicado: (2023)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Moretti, Myla E., et al.
Publicado: (2012)

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
por: Moore, Graham J., et al.
Publicado: (2021)

Vasoplegia in patients with sepsis and septic shock: pathways and mechanisms
por: Burgdorff, A.-M., et al.
Publicado: (2018)

The Use of Methylene Blue during Liver Transplantation for Vasoplegia
por: Harding, Paul, et al.
Publicado: (2021)

Commentary: Vasoplegia after aortic surgery: Looking for options
por: Serna-Gallegos, Derek, et al.
Publicado: (2020)

Ketamine, Interleukin-6, and Vasoplegia: Is Prevention the Best Medicine?
por: Ortoleva, Jamel P.
Publicado: (2023)

Vasoplegia during radical prostatectomy: Methylene blue to rescue
por: Manish, Tandon, et al.
Publicado: (2023)

Redox-sensitive calcium/calmodulin-dependent protein kinase IIα in angiotensin II intra-neuronal signaling and hypertension
por: Basu, Urmi, et al.
Publicado: (2019)

Angiotensin II modulates THP-1-like macrophage phenotype and inflammatory signatures via angiotensin II type 1 receptor
por: Barhoumi, Tlili, et al.
Publicado: (2023)

Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II–Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertension
por: AlSiraj, Yasir, et al.
Publicado: (2021)

Pneumonia Risk and Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Liu, Chia-Lin, et al.
Publicado: (2013)

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
por: Lee, Hyun Woo, et al.
Publicado: (2021)

Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
por: Holloway-Kew, Kara L., et al.
Publicado: (2022)

Randomized Evaluation of Beta Blocker and ACE-Inhibitor/Angiotensin Receptor Blocker Treatment for Post Infarct Angina in Patients With Myocardial Infarction With Non-obstructive Coronary Arteries: A MINOCA-BAT Sub Study Rationale and Design
por: Pasupathy, Sivabaskari, et al.
Publicado: (2021)

Angiotensin II during Experimentally Simulated Central Hypovolemia
por: Jensen, Theo Walther, et al.
Publicado: (2016)

Summertime dosage-dependent hypersensitivity to an angiotensin II receptor blocker
por: Forsdyke, Donald R
Publicado: (2015)

Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta‐blockers in patients hospitalized for acute heart failure
por: Carubelli, Valentina, et al.
Publicado: (2021)

High-Dose Hydroxocobalamin for Refractory Vasoplegia Post Cardiac Surgery
por: Bak, Marek A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_blap9sjec7h1d85okkau4hue4t